Explore current insights into the clinical possibilities posed by organoids and delve into short and long-term prospects for therapeutic screening and personalised regenerative medicine in this whitepaper.
Rapid advances in cell culture and stem cell technology have given rise to organoids: multicellular structures derived from induced pluripotent stem cells or adult stem cells, which imitate the precise cellular heterogeneity, assembly and functionality of human organs.
In this article, we explore current insights into the clinical possibilities posed by organoids and position the short and long-term prospects for organoids in therapeutic screening and personalised regenerative medicine.
Download Now
Asset 1: Organoids: How close are we to the clinic?
PDF, Size 0 kb
